Acotec Scientific Holdings Limited reported no changes in its share structure for the month ended 30 June 2026, according to the Monthly Return filed with Hong Kong Exchanges and Clearing Limited on 2 July 2026.

Key data points:

• Authorised share capital remained at 10.00 billion ordinary shares with a par value of USD 0.00001 each, representing total authorised capital of USD 0.10 million.

• Issued share capital was unchanged at 313.39 million ordinary shares. The company continues to hold zero treasury shares, leaving total issued shares at the same 313.39 million figure.

• No share options, warrants, convertibles, restricted share units, share awards, or other equity instruments were exercised, issued, or cancelled during the month, resulting in a net change of zero shares.

• Acotec confirmed that it met the Hong Kong Main Board’s minimum 25 % public-float requirement as of 30 June 2026.

• The filing was authorised by Director Ms Jing Li, who attested that all applicable regulatory and listing rule obligations have been satisfied.

The absence of share-capital movements signals a period of stability for Acotec’s equity structure, while continued compliance with public-float rules supports orderly trading of its shares on the Hong Kong Stock Exchange.